These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38387335)
1. Identification of 3-aryl-5-methyl-isoxazole-4-carboxamide derivatives and analogs as novel HIF-2α agonists through docking-based virtual screening and structural modification. Chen S; Liu Y; Wang Z; Qi C; Yu Y; Xu L; Hou T; Sheng R Eur J Med Chem; 2024 Mar; 268():116227. PubMed ID: 38387335 [TBL] [Abstract][Full Text] [Related]
2. Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia. Yu Y; Yang F; Yu Q; Liu S; Wu C; Su K; Yang L; Bao X; Li Z; Li X; Zhang X J Med Chem; 2021 Dec; 64(23):17384-17402. PubMed ID: 34709043 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations. Yazdani B; Sirous H; Enguita FJ; Brogi S; Wing PAC; Fassihi A Mol Divers; 2024 Jun; 28(3):1203-1224. PubMed ID: 37120484 [TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. Rosenberger C; Mandriota S; Jürgensen JS; Wiesener MS; Hörstrup JH; Frei U; Ratcliffe PJ; Maxwell PH; Bachmann S; Eckardt KU J Am Soc Nephrol; 2002 Jul; 13(7):1721-32. PubMed ID: 12089367 [TBL] [Abstract][Full Text] [Related]
6. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma. Gong K; Zhang N; Zhang K; Na Y Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786 [TBL] [Abstract][Full Text] [Related]
7. Effects of PHD and HSP90 on erythropoietin production in yak (Bos grunniens) renal interstitial fibroblast-like cells under hypoxia. Cui Y; Li H; Yu SJ; Afedo SY; Bai XF J Mol Histol; 2022 Apr; 53(2):395-411. PubMed ID: 35084636 [TBL] [Abstract][Full Text] [Related]
8. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. Warnecke C; Zaborowska Z; Kurreck J; Erdmann VA; Frei U; Wiesener M; Eckardt KU FASEB J; 2004 Sep; 18(12):1462-4. PubMed ID: 15240563 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
10. Subcellular localization and regulation of hypoxia-inducible factor-2alpha in vascular endothelial cells. Takahashi R; Kobayashi C; Kondo Y; Nakatani Y; Kudo I; Kunimoto M; Imura N; Hara S Biochem Biophys Res Commun; 2004 Apr; 317(1):84-91. PubMed ID: 15047151 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Park SK; Dadak AM; Haase VH; Fontana L; Giaccia AJ; Johnson RS Mol Cell Biol; 2003 Jul; 23(14):4959-71. PubMed ID: 12832481 [TBL] [Abstract][Full Text] [Related]
12. Impaired expression of HIF-2α induces compensatory expression of HIF-1α for the recovery from anemia. Tsuboi I; Yamashita T; Nagano M; Kimura K; To'a Salazar G; Ohneda O J Cell Physiol; 2015 Jul; 230(7):1534-48. PubMed ID: 25557133 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Hu CJ; Iyer S; Sataur A; Covello KL; Chodosh LA; Simon MC Mol Cell Biol; 2006 May; 26(9):3514-26. PubMed ID: 16611993 [TBL] [Abstract][Full Text] [Related]
14. Discovery of Cycloalkyl[ Buchstaller HP; Sala-Hojman A; Leiendecker M; Albers J; Anlauf U; Berges N; Dong L; Fuchß T; Germann M; Knehans T; Krier M; Lecomte M; Müller D; Müller SR; Leuthner B; Lindemann R; Musil D; Nowak M; Reither V; Rettig C; Schindler CEM; Pakulska U; Spuck D; Wegener A; Zarębski A J Med Chem; 2023 Jul; 66(13):8666-8686. PubMed ID: 37403966 [TBL] [Abstract][Full Text] [Related]
15. HIF-1 and HIF-2: working alone or together in hypoxia? Ratcliffe PJ J Clin Invest; 2007 Apr; 117(4):862-5. PubMed ID: 17404612 [TBL] [Abstract][Full Text] [Related]
16. Bidirectional modulation of HIF-2 activity through chemical ligands. Wu D; Su X; Lu J; Li S; Hood BL; Vasile S; Potluri N; Diao X; Kim Y; Khorasanizadeh S; Rastinejad F Nat Chem Biol; 2019 Apr; 15(4):367-376. PubMed ID: 30804532 [TBL] [Abstract][Full Text] [Related]
17. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease. Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538 [TBL] [Abstract][Full Text] [Related]